Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Farhat Nasim
    Farhat Nasim

      Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      • Home
      • Farhat Nasim

      Articles By : Farhat Nasim

      Roche gets European approval for Tecentriq in combo with Avastin, chemotherapy

      Roche gets European approval for Tecentriq in combo with Avastin, chemotherapy

      Farhat Nasim10 March 2019 9:30 AM IST
      ZURICH: Roche has received European Commission approval for its Tecentriq drug in combination with Avastin and chemotherapy as an initial treatment...
      Baxter gets USFDA nod to Cardiovascular Medicine Eptifibatide

      Baxter gets USFDA nod to Cardiovascular Medicine Eptifibatide

      Farhat Nasim10 March 2019 9:25 AM IST
      Eptifibatide is a platelet aggregation inhibitor that prevents platelets—specialized blood cells—from sticking together and clotting.DEERFIELD: Baxter...
      Vertex Pharma Cystic Fibrosis Triple Combo Therapy succeed trials

      Vertex Pharma Cystic Fibrosis Triple Combo Therapy succeed trials

      Farhat Nasim10 March 2019 9:00 AM IST
      Vertex Pharma was the first company to bring to market drugs that address the underlying cause of the disease rather than just symptoms.U.S: Vertex...
      Facebook to remove misleading information on vaccines

      Facebook to remove misleading information on vaccines

      Farhat Nasim9 March 2019 9:50 AM IST
      Facebook also will remove the misleading content from search recommendations and predictions, reject advertisements found to contain misinformation...
      Three US executions delayed over lethal injection drug

      Three US executions delayed over lethal injection drug

      Farhat Nasim9 March 2019 9:20 AM IST
      Chicago: The governor of the US state of Ohio on Thursday delayed three scheduled executions over concerns that a drug currently used in lethal...
      Canada advisory group calls for new prescription drug agency

      Canada advisory group calls for new prescription drug agency

      Farhat Nasim9 March 2019 9:00 AM IST
      Finance Minister Bill Morneau said last month that the federal budget, set to be released on March 19, would outline ways to provide more access to...
      Marksans Pharma gets 8 USFDA observations for its Goa facility

      Marksans Pharma gets 8 USFDA observations for its Goa facility

      Farhat Nasim8 March 2019 10:00 AM IST
      Though Marksans did not provide any details about the observations, it said that none of these observations is considered either critical or...
      Lupin gets USFDA nod for Atorvastatin Calcium tablets to lower cholesterol

      Lupin gets USFDA nod for Atorvastatin Calcium tablets to lower cholesterol

      Farhat Nasim8 March 2019 9:45 AM IST
      Atorvastatin Calcium tablets are indicated to lower cholesterol in blood for adults and children over 10 years of age, Lupin said. It works by...
      Government must have compulsive licensing for essential drugs : Chairman, Cipla

      Government must have compulsive licensing for essential drugs : Chairman, Cipla

      Farhat Nasim8 March 2019 9:30 AM IST
      Cipla Chairman, Y K Hamied said that many drugs which are not covered under patent should be made in India which is not happening at present, citing...
      French court dismisses damage claims against Merck over Levothyrox

      French court dismisses damage claims against Merck over Levothyrox

      Farhat Nasim8 March 2019 9:15 AM IST
      The plaintiffs had accused Merck of not providing sufficient information regarding changes to the Levothyrox.France: A court in the French city of...
      Allergan depression drug fails trial, loses over Rs 100 crore expected sales

      Allergan depression drug fails trial, loses over Rs 100 crore expected sales

      Farhat Nasim8 March 2019 9:00 AM IST
      Stanicky said the data was the most anticipated release of the year and likely means that Allergan will lose what had been expected to be a $1 billion...
      Biocon gets 6 USFDA observations for Bengaluru plant

      Biocon gets 6 USFDA observations for Bengaluru plant

      Farhat Nasim7 March 2019 9:45 AM IST
      The United States Food and Drug Administration (USFDA) concluded a pre-approval inspection of Biocon's insulin drug substance manufacturing facility...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok